MedtechInsight.com

Search
The Newsletter
The Principals
Reports
Conferences
Databases
Custom Research
Contact Us
Home

Online Report Subscribers, Click Here

Pricing and Ordering Information

United Kingdom, Cardiovascular Market Opportunities: Disease Incidence and Prevalence, and Surgical Procedure Volumes
Report #A764 - October 2012
124 Pages – 22 Exhibits

This report presents the disease incidence and prevalence and surgical procedure volumes for selected cardiovascular/peripheral vascular disorders and interventional procedures in the United Kingdom (U.K.); incidence and prevalence figures are compared with those of the Benelux countries (Belgium, Luxembourg, and the Netherlands), the Nordic countries (Denmark, Finland, Norway, and Sweden), and the European Union (EU) countries of Austria, Belgium, Bulgaria, Cyprus, the Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, the Netherlands, Poland, Portugal, Romania, Slovakia, Slovenia, Spain, and Sweden. Among the disorders covered by this report are angina pectoris, cardiac arrhythmia, heart failure, hypertension, and myocardial infarction. Among the covered surgical procedures are coronary artery bypass graft surgery surgery, cardiac resynchronization therapy, congenital heart defect repair, femoropopliteal bypass and stenting, pacemaker/implantable cardioverter defibrillator and ventricular-assist device implantation, percutaneous coronary intervention, percutaneous transluminal angioplasty, peripheral atherectomy, and thrombectomy/ thrombolysis.

Procedure volumes forecasts are for the years 2010-2016, with aggregate figures for the EU countries of France, Germany, Italy, Spain, and the U.K. as well as for the U.K. alone. Disease incidence and prevalence figures are for the year 2010.

In addition to proprietary data utilized from Medtech Insight’s internal resources, many agencies and organizations have provided information including the British Cardiovascular Society/European Society of Cardiology, British Heart Foundation, British Hypertension Society, European Heart Network, European Society of Hypertension, and the World Health Organization, among others.

Ordering Information

Title	Report#	Publication Date	List Price
United Kingdom, Cardiovascular Market Opportunities: Disease Incidence and Prevalence, and Surgical Procedure Volumes	A764	October 2012	$1,995
Order Online: Single User only (Please call for corporate subscription pricing)			PDF Only

Print versions of Reports are available upon request for an additional fee.

Methodology

Reports are produced exclusively by Medtech Insight, through extensive primary and secondary research among the clinicians, researchers, and competitors in the marketplace, and draw upon the industry expertise of a network of industry insiders. Medtech Insight exhaustively corroborates the data as a baseline for completing forward-looking analysis and providing insight into product, technology and market evolution.

TABLE OF CONTENTS

1. OVERVIEW OF CARDIOVASCULAR/PERIPHERAL VASCULAR DISORDERS

1.1 Aneurysm

1.2 Angina Pectoris

1.3 Arrhythmia

1.4 Heart Failure

1.5 Heart Valve Disease

1.6 Hypercholesterolemia and Hypertension

1.7 Myocardial Infarction

1.8 Peripheral Vascular Disease

Exhibit 1-1: United Kingdom, Cardiovascular/Peripheral Vascular Surgery, Procedure Volumes Forecast, by Type, 2010-2016

Exhibit 1-2: United Kingdom, Cardiovascular Disorders, Incidence and Prevalence

2. CARDIOVASCULAR DISORDERS

2.1 Cardiac Arrhythmia

2.1.1 Etiology

2.1.2 Epidemiology

2.2 Heart Failure

2.2.1 Etiology

2.2.2 Epidemiology

2.3 Heart Valve Disorders

2.3.1 Etiology

2.3.2 Epidemiology

2.4 Hypertension

2.4.1 Etiology

2.4.2 Epidemiology

2.5 Vascular Disorders

2.5.1 Aneurysms

2.5.1.1 Etiology

2.5.1.2 Epidemiology

2.5.2 Angina Pectoris

2.5.2.1 Etiology

2.5.2.2 Epidemiology

2.5.3 Atherosclerosis

2.5.3.1 Etiology

2.5.3.2 Epidemiology

2.5.4 Myocardial Infarction

2.5.4.1 Etiology

2.5.4.2 Epidemiology

2.5.5 Peripheral Vascular Disease

2.5.5.1 Etiology

2.5.5.2 Epidemiology

Exhibit 2-1: 2010, United Kingdom and Europe, Atrial Fibrillation, Comparative Incidence and Prevalence

Exhibit 2-2: 2010, United Kingdom and Europe, Atrial Flutter, Comparative Incidence and Prevalence

Exhibit 2-3: 2010, United Kingdom and Europe, Supraventricular Tachycardia, Comparative Incidence and Prevalence

Exhibit 2-4: 2010, United Kingdom and Europe, Heart Failure, Comparative Incidence and Prevalence, by Gender

Exhibit 2-5: 2010, United Kingdom and Europe, Heart Valve Disorders, Comparative Incidence and Prevalence, by Gender

Exhibit 2-6: 2010, United Kingdom and Europe, Hypertension, Comparative Incidence and Prevalence

Exhibit 2-7: 2010, United Kingdom and Europe, Aneurysms, Comparative Incidence and Prevalence

Exhibit 2-8: Standard Angina Pectoris Classification

Exhibit 2-9: 2010, United Kingdom and Europe, Angina Pectoris, Comparative Incidence and Prevalence, by Gender

Exhibit 2-10: United Kingdom and Europe, Hypercholesterolemia, Comparative Prevalence, by Gender and Selected Country

Exhibit 2-11: 2010, United Kingdom and Europe, Myocardial Infarction, Comparative Incidence and Prevalence, by Gender

Exhibit 2-12: 2010, United Kingdom and Europe, Peripheral Vascular Disease, Comparative Incidence and Prevalence

3. CARDIOVASCULAR/PERIPHERAL VASCULAR SURGICAL PROCEDURES

3.1 Arrhythmia

3.1.1 Atrial Fibrillation

3.1.2 Supraventricular Tachycardia

3.1.3 Ventricular Fibrillation

3.1.4 Ventricular Tachycardia

3.2 Circulatory Disorders

3.2.1 Coronary Artery Disease

3.2.2 Myocardial Infarction

3.2.3 Angina Pectoris

3.2.4Aortic Aneurysm

3.2.5 Atherosclerosis

3.2.6 Hypercholesterolemia

3.2.7 Hypertension

3.2.8 Venous Thromboembolism: Deep Vein Thrombosis and Pulmonary Embolism

3.3 Myocardial Diseases/Disorders

3.3.1 Congenital Heart Defects

3.3.2 Heart Failure

3.3.3 Rheumatic Heart Disease

3.3.4 Valvular Heart Disease

3.4 Aneurysm Repair

3.5 Coronary Artery Disease Treatment

3.5.1 Coronary Artery Bypass Graft Surgery

3.5.1.1 Less Invasive Coronary Artery Bypass Graft Techniques

3.5.2 Percutaneous Transluminal Coronary Angioplasty/Coronary Stenting

3.5.3 Transmyocardial Revascularization

3.5.4 Atherectomy

3.5.5 Thrombectomy and Thrombolysis

3.6 Peripheral Vascular Disease and Treatment

3.6.1 Femoropopliteal Bypass

3.6.2 Peripheral Percutaneous Revascularization Techniques

3.6.2.1 Peripheral Percutaneous Transluminal Angioplasty

3.6.2.2 Peripheral Atherectomy

3.6.2.3 Peripheral Femoropopliteal Stenting

3.7 Heart Defect Repair

3.7.1 Congenital Heart Defect Repair

3.7.2 Heart Valve Repair and Replacement

3.8 Cardiac Device Implantation

3.8.1 Cardiac Resynchronization Therapy

3.8.2 Pacemakers

3.8.3 Implantable Cardioverter Defibrillators

3.8.4 Ventricular Assist Devices

Exhibit 3-1: United Kingdom, Aneurysm Repair, Procedure Volumes Forecast, by Type, 2010-2016

Exhibit 3-2: United Kingdom, Coronary Artery Bypass Graft Surgery, Procedure Volumes Forecast, by Type, 2010-2016

Exhibit 3-3: United Kingdom, Percutaneous Coronary Interventions/Stenting, Procedure Volumes Forecast, by Type, 2010-2016

Exhibit 3-4: United Kingdom, Transmyocardial Revascularization, Procedure Volumes Forecast, 2010-2016

Exhibit 3-5: United Kingdom, Thrombectomy and Thrombolysis, Procedure Volumes Forecast, 2010-2016

Exhibit 3-6: United Kingdom, Peripheral Vascular Disease Treatment, Procedure Volumes Forecast, by Type, 2010-2016

Exhibit 3-7: United Kingdom, Heart Defect Repair, Procedure Volumes Forecast, by Type, 2010-2016

Exhibit 3-8: United Kingdom, Cardiac Device Implantation, Procedure Volumes Forecast, by Type, 2010-2016

To order reports or obtain information about special pre-publication offers from within the U.S., contact reports@elsevier.com. You can also call 1.949.453.0071 (or toll-free within the U.S. at 1.888.290.2225) or fax 1.949.453.0072.